Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 74Lung Neoplasms 35Adenocarcinoma of Lung 6Pancoast Syndrome 2NSCLC 2Mesothelioma, Malignant 2Carcinoma 2Unresectable Non-small Cell Lung Cancer 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1SCLC, Limited Stage 1Respiratory Aspiration 1Resectable Non-small Cell Lung Cancer 1Pulmonary Disease, Chronic Obstructive 1Pleural Neoplasms 1Pleural Effusion, Malignant 1Pleural Effusion 1Pleural Diseases 1Peritoneal Neoplasms 1Pathologic Complete Response 1Ovarian Neoplasms 1Mesothelioma 1Locally Advanced Non-Small Cell Lung Cancer 1Limited Stage Small Cell Lung Cancer 1II-IIIB (T3N2) Resectable Non-small Cell Lung Cancer 1Esophageal Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1Adenocarcinoma, Bronchiolo-Alveolar 1Acute Kidney Injury 1

Interventions

Pemetrexed 2durvalumab 1Tretinoin 1Surgical Procedures, Operative 1Paclitaxel 1Observation 1Gemcitabine 1Cisplatin 1Carboplatin 1Bortezomib 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pathologic Complete Response × Surgical Procedures, Operative × Thoracic × Clear all
NCT06743555 2026-04-28

SAVED LUNG

Centre hospitalier de l'Université de Montréal (CHUM)

Phase 1 Not yet recruiting
14 enrolled
Thoracic

Pathologic Complete Response, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡